Search

Your search keyword '"Petrousjka van den Tol M"' showing total 6 results
Start Over Author "Petrousjka van den Tol M" Publication Year Range Last 50 years
6 results on '"Petrousjka van den Tol M"'

1. Figure S1 from Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials

Author

Koster, Bas D., primary, van den Hout, Mari F.C.M., primary, Sluijter, Berbel J.R., primary, Molenkamp, Barbara G., primary, Vuylsteke, Ronald J.C.L.M., primary, Baars, Arnold, primary, van Leeuwen, Paul A.M., primary, Scheper, Rik J., primary, Petrousjka van den Tol, M., primary, van den Eertwegh, Alfons J.M., primary, and de Gruijl, Tanja D., primary

Published
2023
Full Text
View/download PDF

2. Hospital variation in combined liver resection and thermal ablation for colorectal liver metastases and impact on short-term postoperative outcomes: a nationwide population-based study

Author

Elfrink, Arthur K.E., Nieuwenhuizen, Sanne, Petrousjka van den Tol, M., Burgmans, Mark C., Prevoo, Warner, Coolsen, Marielle M.E., Boezem, P.B. van den, Kok, N.F.M., Meijerink, Martijn R., Swijnenburg, Rutger-Jan, Elfrink, Arthur K.E., Nieuwenhuizen, Sanne, Petrousjka van den Tol, M., Burgmans, Mark C., Prevoo, Warner, Coolsen, Marielle M.E., Boezem, P.B. van den, Kok, N.F.M., Meijerink, Martijn R., and Swijnenburg, Rutger-Jan

Abstract

Item does not contain fulltext

Published
2021

3. Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials

Author

Koster, Bas D., primary, van den Hout, Mari F.C.M., additional, Sluijter, Berbel J.R., additional, Molenkamp, Barbara G., additional, Vuylsteke, Ronald J.C.L.M., additional, Baars, Arnold, additional, van Leeuwen, Paul A.M., additional, Scheper, Rik J., additional, Petrousjka van den Tol, M., additional, van den Eertwegh, Alfons J.M., additional, and de Gruijl, Tanja D., additional

Published
2017
Full Text
View/download PDF

4. Mammasparende chirurgie voor borstkanker

Author

Krekel, Nicole M.A., Haloua, Max H., Muller, Sandra, Bergers, Elisabeth, Rietveld, Derek H.F., Meijer, Sybren, Petrousjka Van Den Tol, M., Plastic, Reconstructive and Hand Surgery, Surgery, CCA - Oncogenesis, and Radiation Oncology

Published
2012

6. [Fluorodeoxyglucose F18(FDG)-probe guided biopsy].

Author

Hartemink KJ, Muller S, Smulders YM, Petrousjka van den Tol M, and Comans EF

Subjects
Biopsy instrumentation, Humans, Inflammation diagnosis, Neoplasms diagnosis, Biopsy methods, Fluorodeoxyglucose F18, Inflammation diagnostic imaging, Neoplasms diagnostic imaging, Positron-Emission Tomography methods, Radiopharmaceuticals
Abstract

Although positron emission tomography-computed tomography (PET-CT) has improved the diagnosis of malignant and inflammatory abnormalities, histopathological examination is often required to supplement imaging examination in order to make a definite diagnosis. In some cases a lesion is not visible using conventional imaging techniques but is visible on a PET scan with fluorodeoxyglucose F18 (FDG). In other cases a lesion cannot be approached percutanuously because of localisation or size of the lesion. In these cases the surgeon can now perform an FDG-probe guided biopsy or resection. Using this technique the surgeon can peroperatively detect lesions that have taken up radioactive FDG - so-called FDG-avid lesions - and excise these for histopathological examination. This technique reduces the inadvertent excision of non-representative tissue and can be of value for localising FDG-avid lesions for total resections. FDG-probe guided surgery can potentially increase the sensitivity of diagnostic resections.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results